UK tax break to yield big GSK manufacturing investment

GlaxoSmithKline says it plans to use the UK's upcoming 10-percent "patent box" tax break to scale up current manufacturing and build "a significant new plant." It says it will also develop technology in what may turn out to be the windfall that the UK government is hoping for, with the promise of 1,000 jobs. Article

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.